NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









LatchBio

LatchBio

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://latch.bio/

Last Round

Series A

Jun 2, 2022

Est. Valuation

$25M

Total Funding Raised

$33M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

LatchBio is a biotechnology company that provides a cloud-based, no-code bioinformatics platform designed to help researchers store, analyze, and visualize biological data.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Cloud Infrastructure, Data Integration

Business Model

B2B

Customer Profile

Usage-Based SaaS

AI Layer

Infrastructure

Keywords

bioinformatics platformmulti-omics dataspatial transcriptomicsAI agentsbiotech data infrastructureusage-based billingcloud-native biologydrug discovery softwarebio-data engineeringagentic AIworkflow orchestrationbiotech SaaSdata silosbio-computeAI-native biology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

LatchBio Comparables

Compare LatchBio with similar companies based on industry and business-model similarity.

LatchBio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Pluto Biosciences
81%
Seqera
78%
DNAnexus
77%

LatchBio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJun 2, 2022
SeedOct 1, 2021

Key People

Founding team and executive leadership

Kenny Workman

Co-Founder And CTO

Founding Team

Kyle Giffin

Co-Founder COO

Founding Team

LatchBio Investors

Notable investors and investment history

LatchBio investors
InvestorRounds
HaystackSeed, Series A
Lux CapitalSeed, Series A
General CatalystSeed
Caffeinated CapitalSeries A
Fifty YearsSeed, Series A
Coatue ManagementSeries A
Hummingbird VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 22, 2026

    Grew 78% QoQ from 23 to 41 employees.

  • Apr 28, 2026

    Added Quantumleaphealthcare, a healthcare/biotech company, as a customer.

LatchBio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

LatchBio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about LatchBio's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range41
Year Founded2021
Last FundingJun 2, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.